Symbol Lookup

Saturday May 25, 2013 8:11 AM ET. Data delayed 15 minutes.
95.23
-0.97 (-1.01%)
Bid/Lots
95.19/1
Ask/Lots
95.23/5
Open/Prev Close
95.66/96.20
Day Range
94.00-96.07
52-Week Range
41.26-101.57
Vol/Avg Daily Vol
464.3K/1.0M

ONXX Article

Go

May 21, 2013

Onyx Pharmaceuticals Announces Data Presentations at the 18th Congress of the European Hematology Association
4:00PM ET on Tuesday May 21, 2013 by Marketwire
Companies Mentioned: ONXX

Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced the upcoming presentation of data highlighting Kyprolis(R) (carfilzomib) for Injection, a second-generation proteasome inhibitor, and oprozomib, an oral proteasome inhibitor in early dev...

May 17, 2013

OPTIONS: Option Implied Volatility Mixed into 2013 Annual Meeting of American Society of Clinical Oncology (ASCO) 5/31-6/4
8:41AM ET on Friday May 17, 2013 by Midnight Trader
Companies Mentioned: GILD, INCY, MDVN, ONXX, PCYC, AMGN, ARIA, ABBV, AZN, BMRN, ROSG, CELG, DNDN
08:41 AM EDT, 05/17/2013 (MidnightTrader) -- Option implied volatility is mixed into the 2013 annual meeting of the American Society of Clinical Oncology (ASCO) from May 31 to June 4. AbbVie (ABBV) over all option implied volatility of 25 is ab...

May 15, 2013

Onyx Pharmaceuticals Announces Data Presentations at 49th American Society of Clinical Oncology Annual Meeting
6:00PM ET on Wednesday May 15, 2013 by Marketwire
Companies Mentioned: ONXX

Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced the upcoming presentations of data highlighting Nexavar(R) (sorafenib) tablets, Kyprolis(R) (carfilzomib) for Injection, and Stivarga(R) (regorafenib) tablets across a range of cancers. ...

May 14, 2013

In Relapsed/Refractory Multiple Myeloma, Thought Leaders Are Optimistic that the Combination of Carfilzomib, Lenalidomide and Dexamethasone Will Be the Most Efficacious Regimen
10:05AM ET on Tuesday May 14, 2013 by PR Newswire
Companies Mentioned: ONXX, CELGZ

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. and European hematological oncologists indicate that overall survival is the factor that most influenc...

May 8, 2013

Onyx Pharmaceuticals to Present at Upcoming Investor Conferences
4:00PM ET on Wednesday May 08, 2013 by Marketwire
Companies Mentioned: ONXX

Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced that it will present at two upcoming investor conferences in May.

Bank of America Merrill Lynch 2013 Health Care Conference Onyx will present at the Bank of America Merrill Lynch...

MTNewswires' Pre-Market Trading Ranges
8:27AM ET on Wednesday May 08, 2013 by Midnight Trader
Companies Mentioned: KGC, MYGN, AOL, CIE, ONXX, TSLA, LEDR, DDD, SODA, VCLK, WFM, WILC, CHRW, CTSH
08:27 AM EDT, 05/08/2013 (MidnightTrader) -- Some of the stocks moving on news-driven events in today's pre-market, including their respective trading ranges: UPSIDE MOVERS LEDR: 9.61 to 11.10 MYGN: 28.30 to 30.99 WFM: 92.80 to 100.30 WILC: 6...
MTNewswires' Pre-Market News Movers
8:21AM ET on Wednesday May 08, 2013 by Midnight Trader
Companies Mentioned: KGC, MYGN, AOL, CIE, ONXX, TSLA, LEDR, DDD, SODA, VCLK, WFM, WILC, CHRW, CTSH
08:21 AM EDT, 05/08/2013 (MidnightTrader) -- Some of the stocks moving on news-driven events in today's pre-market include: LEDR, +12.59% MYGN, +9.54% WFM, +8.41% WILC, +1.31% CTSH, +3.56% KGC, +2.08% ONXX, +3.42% TSLA, +2.27% CHRW, -6.76% SODA...

May 7, 2013

Onyx Pharmaceuticals Up 2% in After Hours - Reports Narrower Q1 Loss Vs. Street, Beats on Revenues
4:09PM ET on Tuesday May 07, 2013 by Midnight Trader
Companies Mentioned: ONXX
04:09 PM EDT, 05/07/2013 (MidnightTrader) -- Onyx Pharmaceuticals (ONXX) is up 2.34% at $92.67 in the after hours session after it reported a Q1 loss of $0.47 per share, and adjusted loss of $0.19 per share, beating the Capital IQ consensus estim...
Onyx Pharmaceuticals Reports First Quarter 2013 Financial Results
4:00PM ET on Tuesday May 07, 2013 by Marketwire
Companies Mentioned: ONXX

Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today reported its financial results for the first quarter 2013 and provided a business update on Kyprolis(R) (carfilzomib) for Injection, Nexavar(R) (sorafenib) tablets and Stivarga(R) (regorafenib) ta...

Trade the Earnings: Onyx Pharmaceuticals Inc
6:41AM ET on Tuesday May 07, 2013 by Midnight Trader
Companies Mentioned: ONXX
06:41 AM EDT, 05/07/2013 (MidnightTrader) -- Earnings Release Date: 05/07/2013 Time: After-hours Avg. Extended-Hours Dollar Volume: $217,187,575 Earnings Sensitivity (up or down): 3.1% Onyx Pharmaceuticals Inc (ONXX) is due to issue its quarterly...
← Newer12Older →